IMAX Corporation filings document the formal records behind its entertainment-technology business, NYSE-listed common shares and reported operating results. Recent Form 8-K disclosures cover quarterly and annual financial results, global box office metrics, system installations and signings, material agreements and financing activity, including convertible senior notes.
Proxy materials describe board matters, executive compensation, equity awards and shareholder voting items. Other current reports address leadership-continuity and governance disclosures, while filings also identify the company as a Canadian corporation with operations reported through Content Solutions and Technology Products and Services.
Macquarie Group Limited and related entities filed an amended Schedule 13G reporting that they no longer beneficially own any Imax Corp common shares. As of 12/31/2025, Macquarie Group Limited, Macquarie Management Holdings Inc., and Macquarie Investment Management Business Trust each report 0 shares with 0.00% of the class.
The filing shows no sole or shared voting or dispositive power for any of the reporting persons, confirming that their ownership has fallen to 5 percent or less of Imax’s common shares. The firms also certify that any prior holdings were in the ordinary course of business and not for influencing control of Imax.
FMR LLC filed an amended Schedule 13G reporting beneficial ownership of 3,435,348.37 shares of IMAX Corporation common stock, representing 6.4% of the class as of 12/31/2025. FMR has sole voting power over 3,432,291 shares and sole dispositive power over 3,435,348.37 shares.
Abigail P. Johnson is also reported as a beneficial owner of the same 3,435,348.37 shares, with sole dispositive power and no voting power. The securities are certified as acquired and held in the ordinary course of business, not for the purpose of changing or influencing control of IMAX.
IMAX Corporation’s major shareholder group has updated its ownership disclosure in an Amendment No. 10 to Schedule 13D. Kevin Douglas reports beneficial ownership of 8,885,073 IMAX common shares, representing 16.5% of the company, based on 53,798,934 shares outstanding as of September 30, 2025. His wife, Michelle Douglas, reports 6,509,439 shares, or 12.1%, and James E. Douglas, III reports 1,363,645 shares, or 2.5%.
The filing details how these holdings are spread across multiple California trusts and Celtic Financial LLC, including the K&M Douglas Trust with 3,862,346 shares and several irrevocable descendant trusts each holding 646,110 or 646,111 shares. It explains that Kevin and Michelle Douglas act as co‑trustees on several of these entities and that Kevin Douglas manages Celtic Financial LLC, which holds 571,989 shares. The amendment also notes that the filers have not executed any IMAX share transactions in the last 60 days.
IMAX Corporation chief executive officer and director Richard L. Gelfond reported multiple equity transactions on January 2, 2026 involving IMAX common shares and restricted share units. Vested restricted share units were converted into common shares at an exercise price of $0.00, and a portion of those shares was withheld at a price of $36.02 per share to cover related tax obligations. Following these transactions, Mr. Gelfond beneficially owns 635,940 IMAX common shares directly, along with outstanding equity awards consisting of 1,818,695 options and 231,562 restricted share units. The restricted share units are scheduled to vest in installments through January 2, 2029, each unit representing the right to receive one IMAX common share.
Seller Mark Welton has filed a notice of proposed sale of 25000 Class A common shares of IMAX on the NYSE through Merrill Lynch, with an aggregate market value of 982000. The issuer had 53798934 Class A common shares outstanding.
The securities to be sold were acquired on 03/07/2025 via vesting of 18234 RSUs and 6766 PSUs recorded as compensation, with payment dated 03/07/2025. During the past three months, Welton has already sold 49504 Class A common shares, generating gross proceeds of 1743926.91.
IMAX Corp officer Mark Welton, President IMAX Global Theatres, reported a sale of 25,000 common shares on 12/15/2025 at $39.28 per share. The sale was made pursuant to a Rule 10b5-1 Plan dated September 15, 2025.
After this transaction, he beneficially owns 128,323 common shares, and his remaining restricted share unit balance is 70,609.
IMAX Corporation executive Robert D. Lister, the Chief Legal Officer and Senior Executive Vice President, reported a charitable transfer of company stock. On December 11, 2025, he gifted 2,000 common shares of IMAX Corporation to a donor-advised fund, with the shares to be used for charitable purposes. The Form 4 shows the transaction at a price of $0.00, reflecting that this was a gift rather than a sale.
Following this transaction, Mr. Lister beneficially owns 159,421 common shares and holds 70,609 restricted share units. The filing notes that the timing of the gift relates to changes in tax regulations affecting charitable donations that take effect on January 1, 2026.
An affiliate of IMAX has filed a Form 144 notice covering the planned sale of 2,652 common shares through Morgan Stanley Smith Barney LLC on the NYSE, with an indicated aggregate market value of $95,864.23. The filing notes that these common shares were acquired on 11/24/2025 by exercising stock options under a registered plan, with payment made in cash on the same date. The notice also reports that 53,798,934 common shares were outstanding at the time referenced.
IMAX Corporation’s Chief Financial Officer and EVP, Natasha Fernandes, reported an options exercise and share sale involving the company’s common shares. On 11/24/2025, she exercised 2,652 stock options with an exercise price of $22.49 per share, converting them into 2,652 common shares. That same day, she sold 2,652 common shares at an average price of $36.1479 per share, returning her directly held common share balance to 31,257 shares.
The options were originally granted in 2019 and are scheduled to expire on March 7, 2026, having vested in four annual installments between 2020 and 2023. Following these transactions, Ms. Fernandes’ aggregate remaining outstanding restricted share unit balance is 39,734, and her common share balance remains 31,257, reflecting a same-day exercise-and-sale transaction structure.
IMAX Corp: Orbis Investment Management Limited and Allan Gray Australia Pty Ltd filed Amendment No. 4 to Schedule 13G, reporting beneficial ownership in IMAX common stock. They report 5,241,883 shares, representing 9.7% of the class, with the event dated September 30, 2025.
Orbis has sole voting and dispositive power over 5,222,063 shares, and Allan Gray Australia has sole voting and dispositive power over 19,820 shares. The filers certify the holdings were acquired and are held in the ordinary course of business and not to change or influence control. They are classified as non‑U.S. institutions equivalent to investment advisers.